Apollo Endosurgery Inc APEN Fundamentals and Key Ratios

Apollo Endosurgery Inc. (APEN) Fundamentals


Apollo Endosurgery Inc is active in the healthcare sector based in the United States. As a developer of medical devices, Apollo focuses on addressing obesity, as well as other gastrointestinal disorders. Its products are used by general surgeons, bariatric surgeons and gastroenterologists in a variety of settings to provide interventional therapy to patients who suffer from obesity. The company's products include the OverStitch Endoscopic Suturing System, X-Tack Endoscopic HeliX Tacking System, and the Orbera Intragastric Balloon System.

Apollo Endosurgery Inc is active in the healthcare sector based in the United States. As a developer of medical devices, Apollo focuses on addressing obesity, as well as other gastrointestinal disorders. Its products are used by general surgeons, bariatric surgeons and gastroenterologists in a variety of settings to provide interventional therapy to patients who suffer from obesity. The company's products include the OverStitch Endoscopic Suturing System, X-Tack Endoscopic HeliX Tacking System, and the Orbera Intragastric Balloon System.

SHARE INFORMATION
Market Cap	$ 471,212,225
Shares Outstanding	47,549,165
Float	40,489,680
Percent Float	85.15%
Short Interest	0.00
Short Percent Float	0.0%
Short Interest Ratio	0.00
Short Interest Date	-
Latest Fiscal Dividend Per Share	$ 0.00
Latest Fiscal Revenue	$ 62,989,000
Latest Fiscal EPS	$ -0.81
Latest Fiscal Date	2021-12-31

DIVIDENDS
Dividend (3 Years)	$ 0.00
Dividend (5 Years)	$ 0.00
Ex Dividend Date	-
Dividend Rate	$ 0.00
Dividend Yield	0.0%
Payment Cash	-

HOLDERS
Institutions	171
Institutional Holdings Date	2023-02-28
Institutional Bought Previous 3 Months	4,997,429
Institutional Holdings Percent	90.5%
Institutional Sold Previous 3 Months	2,144,878
Insider Holdings Date	2023-02-28
Insider Bought Previous 3 Months	4,397,310
Insider Holdings Percent	9.6
Insider Sold Previous 3 Months	-
Insider Shares Owned	4,014,043

TRADING INFO
52 Week High	$ 10.30
52 Week Low	$ 3.49
52 Week High Change	$ 50.38
21 Day Moving Average	$ 9.9176
21 Day Extended Moving Average	$ 9.9131
50 Day Moving Average	$ 9.9074
50 Day Extended Moving Average	$ 9.7697
200 Day Moving Average	$ 7.3129
200 Day Extended Moving Average	$ 8.1214
10 Day Average Volume	678,386
20 Day Average Volume	1,002,395
30 Day Average Volume	1,209,372
50 Day Average Volume	1,509,730
Alpha	0.015684
Beta	2.3229
Standard Deviation	0.286513
R2	0.190617
7 Day Price Change	$ -0.02
7 Day Percent Change	-0.2%
21 Day Price Change	$ -0.04
21 Day Percent Change	-0.4%
30 Day Price Change	$ -0.02
30 Day Percent Change	-0.2%
Month to Date Price Change	$ -0.02
Month to Date Percent Change	-0.2%
Quarter to Date Price Change	$ -0.06
Quarter to Date Percent Change	-0.6%
180 Day Price Change	$ 4.69
180 Day Percent Change	89.85%
200 Day Price Change	$ 3.94
200 Day Percent Change	66.0%
Year to Date Price Change	$ -0.06
Year to Date Percent Change	-0.6%

PROFITABILITY
EBIT Margin	-45.3%
EBITDA Margin	-41.1%
Pre-Tax Profit Margin	-62.3%
Profit Margin Count	-54.53%
Gross Margin	56.0%
Profit Margin TOT	-54.53%

INCOME STATEMENTS
Revenue	$ 55,542,000
Revenue Per Share	$ 1.1681
Revenue (3 Years)	$ 5.88
Revenue (5 Years)	$ -2.83

FINANCIAL STRENGTH
Price to Tangible Book	14.00
Total Debt To Equity	1.30
Int Coverage	-4.10
Current Ratio	6.00
Leverage Ratio	2.50
Quick Ratio	4.80
Long Term Debt To Capital	0.56

VALUATION MEASURES
PE Ratio	-9.50
Enterprise Value	$ 458,398,225
Price to Sales	8.4839
Price to Free Cash	-20.30
PE High Last 5 Years	-0.20
Price To Book	11.10
Price To Cash Flow	0.00
PE Low Last 5 Years	-3.20
Price to Tangible Book	14.00

MANAGEMENT EFFECTIVENESS
Receivables Turnover	5.10
Invoice Turnover	2.20
Assets Turnover	0.50
Return Assets	-46.18
Return on Equity	-192.68
Return on Capital	-47.26

PROFILE INFO
Issue Type	CS
SEC Type	EQS
Auditor	Moss Adams LLP
CEO	Charles McKhann
Emplyoees	202
Last Audit	UQ
CIK	0001251769
Industry	Medical Devices & Instruments
Sector	Healthcare
NAICS	Surgical and Medical Instrument Manufacturing(339112)

CONTACT INFO
Address	1120 S. Capital of Texas Highway Building 1, Suite 300 Austin, TX 78746
Website	https://www.apolloendo.com
Facsimile	+1 512 279-5105
Telephone	+1 512 279-5100
Email	investor-relations@apolloendo.com

Boards:

Quotes:

APEN